Scinai Immunotherapeutics (SCNI) Gross Margin (2024 - 2026)
Scinai Immunotherapeutics (SCNI) reported Gross Margin of 228.63% for Q1 2026, down 26754.0% on a YoY basis from N/an in Q1 2025, and up 71.46% sequentially from 801.07% in Q2 2025.
Scinai Immunotherapeutics (SCNI) Gross Margin (2024 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 3 years of Gross Margin data on file, last reported at 228.63% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 26754.0% year-over-year to 228.63%; the trailing twelve-month figure through Mar 2026 stood at 174.05% (changed N/A YoY), and the FY2025 full-year result was 181.41%, down 9327.0% from the prior year.
- Gross Margin grew to 228.63% in Q1 2026, from 801.07% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 38.91% in Q1 2025 to a low of 801.07% in Q2 2025.
- A 3-year average of 244.01% and a median of 148.21% in 2024 frame the typical range for Gross Margin.
- Peak annual rise in Gross Margin reached 26754 bps in 2026, while the deepest fall reached 26754 bps in 2026.
- Tracing SCNI's Gross Margin over 3 years: stood at 81.07% in 2024, then sank by 888 bps to 801.07% in 2025, then surged by 71 bps to 228.63% in 2026.
- Business Quant data shows SCNI's Gross Margin at 228.63% in Q1 2026, 801.07% in Q2 2025, and 38.91% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | -228.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -228.63% |
| Jun 30, 2025 | -801.07% |
| Mar 31, 2025 | 38.91% |
| Dec 31, 2024 | -81.07% |
| Sep 30, 2024 | -148.21% |